INCREASED IN-VIVO PLATELET ACTIVATION AND REDUCED INTRAVASCULAR ENDOTHELIUM-DERIVED RELAXING FACTOR AND NITRATE NITRITE PRODUCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS/
M. Udvardy et al., INCREASED IN-VIVO PLATELET ACTIVATION AND REDUCED INTRAVASCULAR ENDOTHELIUM-DERIVED RELAXING FACTOR AND NITRATE NITRITE PRODUCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS/, Platelets, 9(3-4), 1998, pp. 257-260
Limited information seems to be available about the role of reduced en
dothelial production of endothelium-derived relaxing factor (EDRF)-nit
rate/nitrite (NO) in the pathogenesis of diabetic angiopathy in insuli
n-dependent diabetes. A report of urinary and serum nitrate/nitrite, g
lucometabolic parameters, endothelial and in vivo platelet activation
markers of 22 insulin dependent diabetics (IDDM) patients are given. U
rinary and serum nitrate/nitrite concentrations were reduced in IDDM,
This was independent of disease duration, presence of angiopathy and t
he glucometabolic parameters. A significant and inverse correlation of
nitrate/nitrite excretion with endothelial markers (von Willebrand fa
ctor, soluble thrombomodulin) was documented. Moreover, reduced nitrat
e/nitrite excretion was strongly associated with elevated plasmatic be
ta-thromboglobulin levels. EDRF-NO production is reduced in IDDM and t
his reduction correlates with endothelial damage. Decreased nitrate/ni
trite excretion may also influence in vivo platelet function, which re
sults in increased in vivo platelet activation and suggests that the r
educed intravascular production of EDRF-NO might play a role in the pa
thogenesis of angiopathy in IDDM.